[
    {
     "kind": "calendar#event",
     "etag": "\"3289694439414000\"",
     "id": "rb9t1kihd2281g8m5fc0jlspv4",
     "status": "confirmed",
     "htmlLink": "https://www.google.com/calendar/event?eid=cmI5dDFraWhkMjI4MWc4bTVmYzBqbHNwdjQgNWRzbzg1ODk0ODZpcnRqNTNzZGtyNGg2ZWtAZw&ctz=America/Los_Angeles",
     "created": "2022-02-14T14:00:19.000Z",
     "updated": "2022-02-14T14:00:19.707Z",
     "summary": "SPPI SPECTRUM PHARMACEUTICALS PDUFA",
     "description": "2022-11-24 The product has received Fast Track designation and the agency has set a Prescription Drug User Fee Act (PDUFA) date of November 24, 2022. http://www.businesswire.com/news/home/20220211005068/en/Spectrum-Pharmaceuticals-Announces-Acceptance-of-New-Drug-Application-Filing-for-Poziotinib",
     "creator": {
      "email": "fdatracker@gmail.com"
     },
     "organizer": {
      "email": "5dso8589486irtj53sdkr4h6ek@group.calendar.google.com",
      "displayName": "PDUFA",
      "self": true
     },
     "start": {
      "date": "2022-11-24"
     },
     "end": {
      "date": "2022-11-24"
     },
     "iCalUID": "rb9t1kihd2281g8m5fc0jlspv4@google.com",
     "sequence": 0,
     "reminders": {
      "useDefault": false
     },
     "eventType": "default"
    },
    {
     "kind": "calendar#event",
     "etag": "\"3318717612384000\"",
     "id": "aspbroltlucihra7cpu1rsgvt0",
     "status": "confirmed",
     "htmlLink": "https://www.google.com/calendar/event?eid=YXNwYnJvbHRsdWNpaHJhN2NwdTFyc2d2dDAgNWRzbzg1ODk0ODZpcnRqNTNzZGtyNGg2ZWtAZw&ctz=America/Los_Angeles",
     "created": "2022-08-01T13:00:06.000Z",
     "updated": "2022-08-01T13:00:06.192Z",
     "summary": "SGEN SEAGEN INC. PDUFA",
     "description": "2022-11-16 The sBLA was granted Priority Review with a target action date of November 16, 2022. http://www.businesswire.com/news/home/20220728005910/en/Seagen-Reports-Second-Quarter-2022-Financial-Results",
     "creator": {
      "email": "fdatracker@gmail.com"
     },
     "organizer": {
      "email": "5dso8589486irtj53sdkr4h6ek@group.calendar.google.com",
      "displayName": "PDUFA",
      "self": true
     },
     "start": {
      "date": "2022-11-16"
     },
     "end": {
      "date": "2022-11-16"
     },
     "iCalUID": "aspbroltlucihra7cpu1rsgvt0@google.com",
     "sequence": 0,
     "reminders": {
      "useDefault": false
     },
     "eventType": "default"
    },
    {
     "kind": "calendar#event",
     "etag": "\"3320100014360000\"",
     "id": "p717va0t0idb99qdcap0d9g928",
     "status": "confirmed",
     "htmlLink": "https://www.google.com/calendar/event?eid=cDcxN3ZhMHQwaWRiOTlxZGNhcDBkOWc5MjggNWRzbzg1ODk0ODZpcnRqNTNzZGtyNGg2ZWtAZw&ctz=America/Los_Angeles",
     "created": "2022-08-09T13:00:07.000Z",
     "updated": "2022-08-09T13:00:07.180Z",
     "summary": "LGND LIGAND PHARMACEUTICALS INCORPORATED PDUFA",
     "description": "2022-11-17 The FDA assigned a Prescription Drug User Fee Act (PDUFA) target action date of November 17, 2022. http://www.businesswire.com/news/home/20220808005723/en/Ligand-Reports-Second-Quarter-2022-Financial-Results",
     "creator": {
      "email": "fdatracker@gmail.com"
     },
     "organizer": {
      "email": "5dso8589486irtj53sdkr4h6ek@group.calendar.google.com",
      "displayName": "PDUFA",
      "self": true
     },
     "start": {
      "date": "2022-11-17"
     },
     "end": {
      "date": "2022-11-17"
     },
     "iCalUID": "p717va0t0idb99qdcap0d9g928@google.com",
     "sequence": 0,
     "reminders": {
      "useDefault": false
     },
     "eventType": "default"
    },
    {
     "kind": "calendar#event",
     "etag": "\"3320100031144000\"",
     "id": "pg9inh6j8fstthh89q7bc0mm8c",
     "status": "confirmed",
     "htmlLink": "https://www.google.com/calendar/event?eid=cGc5aW5oNmo4ZnN0dGhoODlxN2JjMG1tOGMgNWRzbzg1ODk0ODZpcnRqNTNzZGtyNGg2ZWtAZw&ctz=America/Los_Angeles",
     "created": "2022-08-09T13:00:15.000Z",
     "updated": "2022-08-09T13:00:15.572Z",
     "summary": "MGNX MacroGenics, Inc. PDUFA",
     "description": "2022-11-17 The extended Prescription Drug User Fee Act (PDUFA) target date is November 17, 2022. https://www.globenewswire.com/news-release/2022/08/08/2494235/0/en/MacroGenics-Provides-Update-on-Corporate-Progress-and-Second-Quarter-2022-Financial-Results.html",
     "creator": {
      "email": "fdatracker@gmail.com"
     },
     "organizer": {
      "email": "5dso8589486irtj53sdkr4h6ek@group.calendar.google.com",
      "displayName": "PDUFA",
      "self": true
     },
     "start": {
      "date": "2022-11-17"
     },
     "end": {
      "date": "2022-11-17"
     },
     "iCalUID": "pg9inh6j8fstthh89q7bc0mm8c@google.com",
     "sequence": 0,
     "reminders": {
      "useDefault": false
     },
     "eventType": "default"
    }
   ]